These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6647134)

  • 21. Development of mortality from malignant melanoma in Slovakia compared with Bohemia and some selected countries.
    Somogyi J; Hostýnová E
    Neoplasma; 1971; 18(6):649-56. PubMed ID: 5160905
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of biopsy on the prognosis of cutaneous melanoma of the head and neck.
    Austin JR; Byers RM; Brown WD; Wolf P
    Head Neck; 1996; 18(2):107-17. PubMed ID: 8647675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of the mortality and incidence of cutaneous melanoma in Italy].
    Maggini M; Petrelli G; Portoghesi F; Vollono C
    Ann Ist Super Sanita; 1982; 18(3):591-4. PubMed ID: 7187848
    [No Abstract]   [Full Text] [Related]  

  • 24. [The controversial aspects in malignant cutaneous melanoma].
    Ordóñez Gallego A; Feliu Batlle J; González Barón M
    Med Clin (Barc); 1993 Jun; 101(3):110-4. PubMed ID: 8315982
    [No Abstract]   [Full Text] [Related]  

  • 25. Vitiligo and melanoma.
    Nordlund JJ; Lerner AB
    Arch Dermatol; 1979 May; 115(5):636. PubMed ID: 443846
    [No Abstract]   [Full Text] [Related]  

  • 26. Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
    Eton O; Kharkevitch DD; Gianan MA; Ross MI; Itoh K; Pride MW; Donawho C; Buzaid AC; Mansfield PF; Lee JE; Legha SS; Plager C; Papadopoulos NE; Bedikian AY; Benjamin RS; Balch CM
    Clin Cancer Res; 1998 Mar; 4(3):619-27. PubMed ID: 9533529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced survival in patients with multiple primary melanoma.
    Doubrovsky A; Menzies SW
    Arch Dermatol; 2003 Aug; 139(8):1013-8. PubMed ID: 12925389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Turning the tables on tumors.
    Mettner J
    Minn Med; 2004 May; 87(5):18-22. PubMed ID: 15191063
    [No Abstract]   [Full Text] [Related]  

  • 29. Time trends of incidence, mortality, and relative survival of invasive skin melanoma in Lithuania.
    Stang A; Valiukeviciene S; Aleknaviciene B; Kurtinaitis J
    Eur J Cancer; 2006 Mar; 42(5):660-7. PubMed ID: 16510281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
    Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of outcome in melanoma patients with cerebral metastases.
    Fife KM; Colman MH; Stevens GN; Firth IC; Moon D; Shannon KF; Harman R; Petersen-Schaefer K; Zacest AC; Besser M; Milton GW; McCarthy WH; Thompson JF
    J Clin Oncol; 2004 Apr; 22(7):1293-300. PubMed ID: 15051777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and treatment of cutaneous melanoma: state of the art 2006.
    Garbe C; Eigentler TK
    Melanoma Res; 2007 Apr; 17(2):117-27. PubMed ID: 17496787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant melanoma. A REVIEW OF ') YEARS' experience in Glasgow, Scotland.
    Cochran AJ
    Cancer; 1969 May; 23(5):1190-9. PubMed ID: 5778237
    [No Abstract]   [Full Text] [Related]  

  • 34. Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells.
    López MN; Pereda C; Segal G; Muñoz L; Aguilera R; González FE; Escobar A; Ginesta A; Reyes D; González R; Mendoza-Naranjo A; Larrondo M; Compán A; Ferrada C; Salazar-Onfray F
    J Clin Oncol; 2009 Feb; 27(6):945-52. PubMed ID: 19139436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
    Lasithiotakis K; Leiter U; Meier F; Eigentler T; Metzler G; Moehrle M; Breuninger H; Garbe C
    Cancer; 2008 Apr; 112(8):1795-804. PubMed ID: 18306371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of the sentinel lymph node. Diagnosis and treatment of cutaneous malignant melanoma stages I and II].
    Denninghoff V; Falco J; Curutchet HP; Elsner B
    Medicina (B Aires); 2006; 66(2):144-6. PubMed ID: 16715764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comment on the contribution by U. Beiteke et al. Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. Second comment].
    Gefeller O; Kleeberg U; Kölmel KF
    Hautarzt; 1994 Mar; 45(3):191-2; author reply 193-4. PubMed ID: 8175352
    [No Abstract]   [Full Text] [Related]  

  • 38. Malignant melanoma.
    Califano J; Nance M
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):337-48. PubMed ID: 19698915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prior pregnancy and melanoma survival.
    Bork K; Bräuninger W
    Arch Dermatol; 1986 Oct; 122(10):1097. PubMed ID: 3767392
    [No Abstract]   [Full Text] [Related]  

  • 40. Is melanoma mortality declining in Spain? Analysis of trends from 1975 to 2016.
    Cayuela A; Cayuela L; Rodríguez-Domínguez S; Lorente AI; Rodríguez de la Borbolla M
    Br J Dermatol; 2018 Oct; 179(4):991-992. PubMed ID: 29758094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.